KoreaTechToday - Korea's Leading Tech and Startup Media Platform
  • Topics
    • Naver
    • Kakao
    • Nexon
    • Netmarble
    • NCsoft
    • Samsung
    • Hyundai
    • SKT
    • LG
    • KT
    • Retail
    • Startup
    • Blockchain
    • government
  • Lists
KoreaTechToday - Korea's Leading Tech and Startup Media Platform
  • Topics
    • Naver
    • Kakao
    • Nexon
    • Netmarble
    • NCsoft
    • Samsung
    • Hyundai
    • SKT
    • LG
    • KT
    • Retail
    • Startup
    • Blockchain
    • government
  • Lists
KoreaTechToday - Korea's Leading Tech and Startup Media Platform
No Result
View All Result
Home Celltrion

Celltrion to Conduct Trials for COVID-19 Test Kit, Cure in Six months

James Jung by James Jung
PUBLISHED: March 13, 2020 UPDATED: March 18, 2020
in Celltrion, South Korea, Virus
0
celltrion-chairman
Celltrion’s Chairman Seo Jung-jin, during a YouTube live stream, saying that the company doubled its efforts to create a super-fast test kit to identify COVID-19 and to develop a cure, with a human clinical trial stage in six months. / photo courtesy of Celltrion

Celltrion’s Chairman Seo Jung-jin, during a YouTube live stream, saying that the company doubled its efforts to create a super-fast test kit to identify COVID-19 and to develop a cure, with a human clinical trial stage in six months. / photo courtesy of Celltrion

Celltrion, South Korea’s leading biosimilar developer, said it doubled its efforts to create a super-fast test kit designed to identify COVID-19 and to develop a cure, which the company foresees would reach human clinical trial stage within six months.

 Seo Jung-jin, Celltrion’s Chairman, shared on a YouTube live stream on Thursday the group’s ongoing efforts on the coronavirus cure development. He said that the company aims to commercialize the kit within three months with a local partner.

Seo said that under normal circumstances, the process would take about 18 months, though, given the emergency in South Korea, they plan to initiate the use of antibodies on confirmed patients after six months. Celltrion would closely work with the Ministry of Food and Drug Safety to conduct the trials.

Celltrion secured a blood sample from a recovered coronavirus patient released from the Seoul National University College of Medicine. The company has also been gathering more samples from other institutes to use for screening antibodies required for the diagnostic kits. The biosimilar developer hopes to narrow down the antibody candidates by the end of March and select the most potent pipeline by the end of April.

The chairman said that as they are developing a cure, they would also develop diagnostic kits that can be used by people without the intervention of a medical professional.

Diasgnostic Kits

Hospitals widely use a method called quantitative reverse transcription PCR (RT-qPCR), but it takes a few hours to acquire results with very high accuracy. Meanwhile, a rapid diagnostic kit works faster but has low accuracy.

Celltrion intends to combine both methods benefiting from their advantages. The company plans to create a kit that could show results within 15 to 20 minutes with high accuracy.

Seo added that the company plans to conduct a phase 1 study to demonstrate safety, and a phase 3 trial for both safety and efficacy and side effects in up to 1,000 patients.

Furthermore, Celltrion would provide a total of 1 million masks to citizens of Cheongju, North Chungcheong Province, and Incheon, Gyeonggi Province. Both cities are where Celltrion’s operation facilities are located, said Seo.

Seo said that the commercial development of the new coronavirus treatment would cost at least $248.8 million (300 billion).

 “We are doing this so that Korea will become an exemplary case for eradicating COVID-19.”

– Celltrion Chairman Seo Jung-jin, during the YouTube live stream

Celltrion is still pursuing to establish China’s biggest biologics drug plant in the city of Wuhan.

Tags: Celltrionclinical trialscoronavirusCOVID-19curediagnostic kitsSouth Korea

Related Posts

South Korea, BlackRock Team Up to Build Hyperscale AI Data Center Hub
Celltrion’s Chairman Seo Jung-jin, during a YouTube live stream, saying that the company doubled its efforts to create a super-fast test kit to identify COVID-19 and to develop a cure, with a human clinical trial stage in six months. / photo courtesy of Celltrion
Data Center

South Korea, BlackRock Team Up to Build Hyperscale AI Data Center Hub

October 1, 2025
Global API Standardization Gets a Push with SK Telecom–Aduna Partnership
Celltrion’s Chairman Seo Jung-jin, during a YouTube live stream, saying that the company doubled its efforts to create a super-fast test kit to identify COVID-19 and to develop a cure, with a human clinical trial stage in six months. / photo courtesy of Celltrion
AI

Global API Standardization Gets a Push with SK Telecom–Aduna Partnership

September 23, 2025
$12B Crypto Wave: How Young Koreans Are Shaping Global Markets
Celltrion’s Chairman Seo Jung-jin, during a YouTube live stream, saying that the company doubled its efforts to create a super-fast test kit to identify COVID-19 and to develop a cure, with a human clinical trial stage in six months. / photo courtesy of Celltrion
Cryptocurrency

$12B Crypto Wave: How Young Koreans Are Shaping Global Markets

September 1, 2025
Caught Between Giants: How U.S. Export Controls Reshape South Korea’s Semiconductor Strategy
Celltrion’s Chairman Seo Jung-jin, during a YouTube live stream, saying that the company doubled its efforts to create a super-fast test kit to identify COVID-19 and to develop a cure, with a human clinical trial stage in six months. / photo courtesy of Celltrion
Samsung

Caught Between Giants: How U.S. Export Controls Reshape South Korea’s Semiconductor Strategy

September 1, 2025
Samsung and SK Hynix Face New U.S. Licensing Rules for Chinese Chip Plants
Celltrion’s Chairman Seo Jung-jin, during a YouTube live stream, saying that the company doubled its efforts to create a super-fast test kit to identify COVID-19 and to develop a cure, with a human clinical trial stage in six months. / photo courtesy of Celltrion
China

Samsung and SK Hynix Face New U.S. Licensing Rules for Chinese Chip Plants

August 31, 2025
South Korea Eyes Global AI Leadership with Record 8.1% Budget Hike
Celltrion’s Chairman Seo Jung-jin, during a YouTube live stream, saying that the company doubled its efforts to create a super-fast test kit to identify COVID-19 and to develop a cure, with a human clinical trial stage in six months. / photo courtesy of Celltrion
AI

South Korea Eyes Global AI Leadership with Record 8.1% Budget Hike

August 30, 2025
No Result
View All Result

Most Popular

  • Ride-Hailing Rivalry: Kakao and Uber Bet on Membership Services in Korea

    0 shares
    Share 0 Tweet 0
  • Kakao Mobility Faces $10.5 Million Fine for Limiting Competitors’ Access to Taxi Platform

    0 shares
    Share 0 Tweet 0
  • Korea’s Navigation Battle Heats Up: Naver and Kakao vs. Google maps

    0 shares
    Share 0 Tweet 0
  • 5 Best Korean to English Translation Apps

    0 shares
    Share 0 Tweet 0
  • Naver Launches 3D Street View for Immersive Navigation Experience

    0 shares
    Share 0 Tweet 0
  • Naver Maps Launches Guide in English, Chinese, and Japanese to Enhance Travel Experience for Tourists

    0 shares
    Share 0 Tweet 0
  • KakaoTalk to Adopt Instagram-Style Feed in Major 2025 Redesign

    0 shares
    Share 0 Tweet 0
  • Naver Unveils Asia’s Largest Data Center, GAK Sejong, for Tech Innovation

    0 shares
    Share 0 Tweet 0
  • Top Nine Mobile MMORPG in South Korea for 2020

    0 shares
    Share 0 Tweet 0
  • LG’s Return to Smartphones: A New AI Collaboration with Samsung

    0 shares
    Share 0 Tweet 0

PRODUCTS

[ads_amazon]

TOPICS

  • Naver
  • Kakao
  • Nexon
  • Netmarble
  • NCsoft
  • Samsung
  • Hyundai

FREE NEWSLETTER

FOLLOW US

  • About Us
  • Cookie policy
  • home
  • homepage
  • mainhome
  • Our Services
  • Privacy Policy
  • Terms of Use

Copyright © 2024 KoreaTechToday | About Us | Terms of Use |Privacy Policy |Cookie Policy| Contact : [email protected] |

No Result
View All Result
  • Topics
    • Naver
    • Kakao
    • Nexon
    • Netmarble
    • NCsoft
    • Samsung
    • Hyundai
    • SKT
    • LG
    • KT
    • Retail
    • Startup
    • Blockchain
    • government
  • Lists

Copyright © 2024 KoreaTechToday | About Us | Terms of Use |Privacy Policy |Cookie Policy| Contact : [email protected] |